51
|
Popova D, Dhadda P, Bell M, Amable P, Murrell J, McCoy R, Callens S, Kerby J, Ward S. Developing integrated single-use upstream and downstream platform processing options for allogeneic cell therapy applications: Linking the stirred tank bioreactor to the TFF. Cytotherapy 2017. [DOI: 10.1016/j.jcyt.2017.02.203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
52
|
O’Shea P, Griffin T, Browne G, Gallagher N, Brady J, Dennedy M, Bell M, Wall D, Fitzgibbon M. Screening for primary aldosteronism using the newly developed IDS-iSYS® automated assay system. Pract Lab Med 2017; 7:6-14. [PMID: 28924583 PMCID: PMC5578353 DOI: 10.1016/j.plabm.2016.11.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2016] [Revised: 10/28/2016] [Accepted: 11/01/2016] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND The recommended approach to screening for primary aldosteronism (PA) in at-risk populations is to determine the ratio of aldosterone concentration (serum (SAC)/plasma (PAC)) to renin measured in plasma as activity (PRA) or concentration (DRC). However, lack of assay standardisation mandates the need for method-specific decision thresholds and clinical validation in the local population. AIM The study objective was to establish method-specific aldosterone: renin ratio (ARR) cut-offs for PA in men and women using the IDS-iSYS® assay system (IDS plc). METHODS A prospective cohort study design was used. PAC and DRC were measured immunochemically in ethylenediamine-tetraacetic acid (EDTA) plasma on the IDS-iSYS® instrument. RESULTS A total of 437 subjects (218 men, 219 women) were recruited including: healthy normotensive volunteers (n=266) and women taking the oral contraceptive pill (OCP; n=15); patients with essential hypertension (EH; n=128); confirmed PA (n=16); adrenal cortical carcinoma (ACC; n=3); Addison's disease (AD; n=4) and phaeochromocytoma/paraganglioma (PPGL; n=5). In this population, an ARR cut-off at >37.4 pmol/mIU provided 100% diagnostic sensitivity, 96% specificity and positive likelihood ratio for PA of 23:1. When the ARR decision threshold was stratified according to gender, a cut-off of >26.1 pmol/mIU in men and >113.6 pmol/mIU in women resulted in diagnostic sensitivity and specificity of 100%. CONCLUSION This study demonstrates that decision thresholds for PA should not only be method-specific but also gender-specific. However, given the small number of PA patients (n=16), particularly women (n=4), further validation through a prospective study with a larger PA cohort is required before the thresholds presented here could be recommended for routine clinical use.
Collapse
|
53
|
Cao B, Stotler DP, Zweben SJ, Bell M, Diallo A, Leblanc B. Comparison of Gas Puff Imaging Data in NSTX with DEGAS 2 Simulations. FUSION SCIENCE AND TECHNOLOGY 2017. [DOI: 10.13182/fst13-a17044] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
54
|
Kilbey A, Terry A, Wotton S, Borland G, Zhang Q, Mackay N, McDonald A, Bell M, Wakelam MJO, Cameron ER, Neil JC. Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis. J Cell Biochem 2017; 118:1432-1441. [PMID: 27869314 PMCID: PMC5408393 DOI: 10.1002/jcb.25802] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2016] [Accepted: 11/18/2016] [Indexed: 12/12/2022]
Abstract
The three‐membered RUNX gene family includes RUNX1, a major mutational target in human leukemias, and displays hallmarks of both tumor suppressors and oncogenes. In mouse models, the Runx genes appear to act as conditional oncogenes, as ectopic expression is growth suppressive in normal cells but drives lymphoma development potently when combined with over‐expressed Myc or loss of p53. Clues to underlying mechanisms emerged previously from murine fibroblasts where ectopic expression of any of the Runx genes promotes survival through direct and indirect regulation of key enzymes in sphingolipid metabolism associated with a shift in the “sphingolipid rheostat” from ceramide to sphingosine‐1‐phosphate (S1P). Testing of this relationship in lymphoma cells was therefore a high priority. We find that ectopic expression of Runx1 in lymphoma cells consistently perturbs the sphingolipid rheostat, whereas an essential physiological role for Runx1 is revealed by reduced S1P levels in normal spleen after partial Cre‐mediated excision. Furthermore, we show that ectopic Runx1 expression confers increased resistance of lymphoma cells to glucocorticoid‐mediated apoptosis, and elucidate the mechanism of cross‐talk between glucocorticoid and sphingolipid metabolism through Sgpp1. Dexamethasone potently induces expression of Sgpp1 in T‐lymphoma cells and drives cell death which is reduced by partial knockdown of Sgpp1 with shRNA or direct transcriptional repression of Sgpp1 by ectopic Runx1. Together these data show that Runx1 plays a role in regulating the sphingolipid rheostat in normal development and that perturbation of this cell fate regulator contributes to Runx‐driven lymphomagenesis. J. Cell. Biochem. 118: 1432–1441, 2017. © 2016 The Authors. Journal of Cellular Biochemistry Published by Wiley Periodicals, Inc.
Collapse
|
55
|
Fischlowitz A, Zimmerman L, Williams P, Henry-Reid L, Bell M, Patel A. Chlamydia trachomatis and neisseria gonorrhoeae screen-and-treat protocol among young women seeking first-trimester medical or surgical abortion at an urban, public hospital. Contraception 2016. [DOI: 10.1016/j.contraception.2016.07.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
56
|
Casey R, Griffin TP, Wall D, Dennedy MC, Bell M, O'Shea PM. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients. Ann Clin Biochem 2016; 54:170-173. [PMID: 27166307 DOI: 10.1177/0004563216646395] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background The Endocrine Society Clinical Practice Guideline on Phaeochomocytoma and Paraganglioma recommends phlebotomy for plasma-free metanephrines with patients fasted and supine using appropriately defined reference intervals. Studies have shown higher diagnostic sensitivities using these criteria. Further, with seated-sampling protocols, for result interpretation, reference intervals that do not compromise diagnostic sensitivity should be employed. Objective To determine the impact on diagnostic performance and financial cost of using supine reference intervals for result interpretation with our current plasma-free metanephrines fasted/seated-sampling protocol. Methods We conducted a retrospective cohort study of patients who underwent screening for PPGL using plasma-free metanephrines from 2009 to 2014 at Galway University Hospitals. Plasma-free metanephrines were measured using liquid chromatography-tandem mass spectrometry. Supine thresholds for plasma normetanephrine and metanephrine set at 610 pmol/L and 310 pmol/L, respectively, were used. Results A total of 183 patients were evaluated. Mean age of participants was 53.4 (±16.3) years. Five of 183 (2.7%) patients had histologically confirmed PPGL (males, n=4). Using seated reference intervals for plasma-free metanephrines, diagnostic sensitivity and specificity were 100% and 98.9%, respectively, with two false-positive cases. Application of reference intervals established in subjects supine and fasted to this cohort gave diagnostic sensitivity of 100% with specificity of 74.7%. Financial analysis of each pretesting strategy demonstrated cost-equivalence (€147.27/patient). Conclusion Our cost analysis, together with the evidence that fasted/supine-sampling for plasma-free metanephrines, offers more reliable exclusion of PPGL mandates changing our current practice. This study highlights the important advantages of standardized diagnostic protocols for plasma-free metanephrines to ensure the highest diagnostic accuracy for investigation of PPGL.
Collapse
|
57
|
Bhoi P, Bessette L, Bell M, Tkaczyk C, Nantel F, Maslova K. AB1040 Comparison of Adherence and Dosing Interval of Subcutaneous anti-TNF Biologics in Inflammatory Arthritis from A Canadian Administrative Database. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3760] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
58
|
Lavoie K, Bell M, Taylor T, Arendse R, Saum M, Faucher D, Shawi M, Camerlain M. FRI0599 Clinician Training in Motivational Communication Skills: The Impact of The Language of Change Program among Rheumatologists from across Canada. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.4359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
59
|
Morley DW, de Hoogh K, Fecht D, Fabbri F, Bell M, Goodman PS, Elliott P, Hodgson S, Hansell AL, Gulliver J. International scale implementation of the CNOSSOS-EU road traffic noise prediction model for epidemiological studies. ENVIRONMENTAL POLLUTION (BARKING, ESSEX : 1987) 2015; 206:332-41. [PMID: 26232738 DOI: 10.1016/j.envpol.2015.07.031] [Citation(s) in RCA: 56] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Revised: 07/16/2015] [Accepted: 07/18/2015] [Indexed: 05/08/2023]
Abstract
The EU-FP7-funded BioSHaRE project is using individual-level data pooled from several national cohort studies in Europe to investigate the relationship of road traffic noise and health. The detailed input data (land cover and traffic characteristics) required for noise exposure modelling are not always available over whole countries while data that are comparable in spatial resolution between different countries is needed for harmonised exposure assessment. Here, we assess the feasibility using the CNOSSOS-EU road traffic noise prediction model with coarser input data in terms of model performance. Starting with a model using the highest resolution datasets, we progressively introduced lower resolution data over five further model runs and compared noise level estimates to measurements. We conclude that a low resolution noise model should provide adequate performance for exposure ranking (Spearman's rank = 0.75; p < 0.001), but with relatively large errors in predicted noise levels (RMSE = 4.46 dB(A)).
Collapse
|
60
|
McCarroll CS, He W, Foote KK, Nather K, Fattah C, Elliott EBA, Cochrane A, Bowman P, Bell M, Kubin T, Braun T, Nicklin SA, Cameron ER, Loughrey CM. 7 Runx1 deficiency protects against adverse cardiac remodelling following myocardial infarction. BRITISH HEART JOURNAL 2015. [DOI: 10.1136/heartjnl-2015-308734.7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
61
|
Hussain S, Panteliou E, Berney DM, Carpenter R, Matson M, Sahdev A, Bell M, O'Sullivan E, Drake WM. Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronism. Endocrinol Diabetes Metab Case Rep 2015; 2015:150064. [PMID: 26273475 PMCID: PMC4533278 DOI: 10.1530/edm-15-0064] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Accepted: 07/21/2015] [Indexed: 11/17/2022] Open
Abstract
We describe a young male patient with longstanding hypertension, who was diagnosed with primary hyperaldosteronism and treated by an attempted retroperitoneoscopic total unilateral adrenalectomy for a left-sided presumed aldosterone-secreting adenoma. Imaging had shown an unremarkable focal adrenal lesion with normal contralateral adrenal morphology, and histology of the resected specimen showed no adverse features. Post-operatively, his blood pressure and serum aldosterone levels fell to the normal range, but 9 months later, his hypertension recurred, primary aldosteronism was again confirmed and he was referred to our centre. Repeat imaging demonstrated an irregular left-sided adrenal lesion with normal contralateral gland appearances. Adrenal venous sampling was performed, which supported unilateral (left-sided) aldosterone hypersecretion. Redo surgery via a laparoscopically assisted transperitoneal approach was performed and multiple nodules were noted extending into the retroperitoneum. It was thought unlikely that complete resection had been achieved. His blood pressure returned to normal post-operatively, although hypokalaemia persisted. Histological examination, from this second operation, showed features of an adrenocortical carcinoma (ACC; including increased mitoses and invasion of fat) that was assessed as malignant using the scoring systems of Weiss and Aubert. Biochemical hyperaldosteronism persisted post-operatively, and detailed urine steroid profiling showed no evidence of adrenal steroid precursors or other mineralocorticoid production. He received flank radiotherapy to the left adrenal bed and continues to receive adjunctive mitotane therapy for a diagnosis of a pure aldosterone-secreting ACC.
Collapse
|
62
|
Garrahy A, Casey R, Wall D, Bell M, O'Shea PM. A review of the management of positive biochemical screening for phaeochromocytoma and paraganglioma: a salutary tale. Int J Clin Pract 2015; 69:802-9. [PMID: 25651433 DOI: 10.1111/ijcp.12612] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
BACKGROUND Phaeochromocytomas (PC) and paragangliomas (PGL) are rare neuroendocrine tumours of chromaffin cells. Diagnosis depends on biochemical evidence of excessive production of catecholamines. This is straightforward when test results are orders of magnitude above the concentrations expected in healthy individuals and those with essential hypertension. Equivocal results pose a management dilemma. AIM We reviewed biochemical screens that were positive and the ensuing management for PC/PGL at our institution. The objective was to inform the development of a standardised approach to investigation and clinical follow-up. METHOD All records of positive biochemical screening for PC/PGL were extracted from the laboratory information system between January 2004 and June 2012. Clinical notes of patients with positive results were reviewed. RESULTS A total of 2749 biochemical screens were performed during the evaluation period. Of these, 106 (3.9%) performed on 82 patients were positive. Chart review determined that 12/82 patients had histologically confirmed PC/PG. Of the 70 patients remaining, the most common indication for biochemical screening was hypertension and the medical subspecialty most frequently requesting the test was Endocrinology. The primary team carried out repeat testing on 35/70 (50%) patients and in 29 results normalised. Notably, 35/70 (50%) patients did not have any follow-up of positive test results. CONCLUSION This study highlights the necessity for a standardised diagnostic protocol for PC/PGL. We suggest that appropriate follow-up of borderline-elevated results should first include repeat biochemical testing. This should be performed under standardised pre-analytical conditions and where possible off all potentially interfering medications, measuring plasma free metadrenalines.
Collapse
|
63
|
Grubb A, Bell M. Cystatin C: More than a renal function marker. Rev Clin Esp 2015; 215:102-3. [PMID: 25626955 DOI: 10.1016/j.rce.2014.11.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2014] [Accepted: 11/16/2014] [Indexed: 10/24/2022]
|
64
|
Casey R, O'Hara MC, Cunningham A, Wall D, Geoghegan R, Hynes L, McGuire B, Gately M, Bell M, Dinneen SF. Young adult type 1 diabetes care in the West of Ireland: an audit of hospital practice. QJM 2014; 107:903-8. [PMID: 24925824 DOI: 10.1093/qjmed/hcu103] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND It is well recognised that management of young adults with type 1 diabetes (T1DM) poses difficult challenges for physicians and health care organisations as a whole. In Ireland and in particular the west of Ireland there has been little audit or research on young adults with T1DM and the services available to them. DESIGN In 2011 a retrospective review of this patient population in our territory referral centre was carried out. RESULTS The average glycaemic control in this population was poor at 81mmols/mol and diabetes related complications were present in 32%. Engagement by this population with services was poor with an average of 3 missed clinic appointments over a 24 month period. CONCLUSION These results have prompted a re think of how health care professionals can deliver a service that better suits the needs of this challenging patient group.
Collapse
|
65
|
Metcalfe S, Hulands-Nave A, Bell M, Kidd C, Pasloske K, O'Hagan B, Perkins N, Whittem T. Multicentre, randomised clinical trial evaluating the efficacy and safety of alfaxalone administered to bitches for induction of anaesthesia prior to caesarean section. Aust Vet J 2014; 92:333-8. [PMID: 25156052 DOI: 10.1111/avj.12223] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/26/2014] [Indexed: 11/26/2022]
|
66
|
Pressman A, Doumit G, Rosaeg O, Bell M. A double-blind randomized controlled trial showing the analgesic and anesthetic properties of lidocaine E to be equivalent to those of ropivicaine and bupivacaine in carpal tunnel release surgery. THE CANADIAN JOURNAL OF PLASTIC SURGERY = JOURNAL CANADIEN DE CHIRURGIE PLASTIQUE 2013; 13:173-6. [PMID: 24227926 DOI: 10.1177/229255030501300401] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In a three-phase trial, the anesthetic properties of lidocaine, bupivacaine and ropivicaine were compared in carpal tunnel release surgery. In phase I, two groups of 25 sequential patients were injected with either lidocaine plain 2% or lidocaine 2% with adrenaline 1:100,000 (E), as the local anesthetic for outpatient carpal tunnel release surgery. Subjective injection pain, postoperative pain at 2 h increments and the number of analgesic pills taken were recorded. During the first postoperative hours, outcome measures were superior in the lidocaine E group. In phase II, a double-blind randomized design compared 42 patients injected with either lidocaine E or a combination of lidocaine E and bupivacaine. Postoperative pain scores and analgesic pills taken were compared using nonparametric statistical tests. During the first 4 h there was a slight benefit in the duration of the anesthetic and fewer pain pills were used in the bupivacaine group. Phase III was a randomized double-blind comparison of ropivicaine and lidocaine E 2% in 72 patients. There was a slight decrease in pain scores and fewer analgesic pills required during the first 6 h in the ropivicaine group. Lidocaine plain 2% provided significantly inferior analgesic and anesthetic properties compared with lidocaine E 2%, bupivacaine or ropivicaine. Sequential randomized comparisons between lidocaine E and bupivacaine and ropivicaine showed clinical equivalence. The present study showed lidocaine E 2% to be a satisfactory and comparatively cost-effective anesthetic for outpatient carpal tunnel surgery.
Collapse
|
67
|
Ambady P, Holdhoff M, Ferrigno C, Grossman S, Anderson MD, Liu D, Conrad C, Penas-Prado M, Gilbert MR, Yung AWK, de Groot J, Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, Kawabata N, Mishima K, Adachi JI, Kurisu K, Yamasaki F, Tominaga T, Kumabe T, Ueki K, Higuchi F, Yamamoto T, Ishikawa E, Takeshima H, Yamashita S, Arita K, Hirano H, Yamada S, Matsutani M, Apok V, Mills S, Soh C, Karabatsou K, Arimappamagan A, Arya S, Majaid M, Somanna S, Santosh V, Schaff L, Armentano F, Harrison C, Lassman A, McKhann G, Iwamoto F, Armstrong T, Yuan Y, Liu D, Acquaye A, Vera-Bolanos E, Diefes K, Heathcock L, Cahill D, Gilbert M, Aldape K, Arrillaga-Romany I, Ruddy K, Greenberg S, Nayak L, Avgeropoulos N, Avgeropoulos G, Riggs G, Reilly C, Banerji N, Bruns P, Hoag M, Gilliland K, Trusheim J, Bekaert L, Borha A, Emery E, Busson A, Guillamo JS, Bell M, Harrison C, Armentano F, Lassman A, Connolly ES, Khandji A, Iwamoto F, Blakeley J, Ye X, Bergner A, Dombi E, Zalewski C, Follmer K, Halpin C, Fayad L, Jacobs M, Baldwin A, Langmead S, Whitcomb T, Jennings D, Widemann B, Plotkin S, Brandes AA, Mason W, Pichler J, Nowak AK, Gil M, Saran F, Revil C, Lutiger B, Carpentier AF, Milojkovic-Kerklaan B, Aftimos P, Altintas S, Jager A, Gladdines W, Lonnqvist F, Soetekouw P, van Linde M, Awada A, Schellens J, Brandsma D, Brenner A, Sun J, Floyd J, Hart C, Eng C, Fichtel L, Gruslova A, Lodi A, Tiziani S, Bridge CA, Baldock A, Kumthekar P, Dilfer P, Johnston SK, Jacobs J, Corwin D, Guyman L, Rockne R, Sonabend A, Cloney M, Canoll P, Swanson KR, Bromberg J, Schouten H, Schaafsma R, Baars J, Brandsma D, Lugtenburg P, van Montfort C, van den Bent M, Doorduijn J, Spalding A, LaRocca R, Haninger D, Saaraswat T, Coombs L, Rai S, Burton E, Burzynski G, Burzynski S, Janicki T, Marszalek A, Burzynski S, Janicki T, Burzynski G, Marszalek A, Cachia D, Smith T, Cardona AF, Mayor LC, Jimenez E, Hakim F, Yepes C, Bermudez S, Useche N, Asencio JL, Mejia JA, Vargas C, Otero JM, Carranza H, Ortiz LD, Cardona AF, Ortiz LD, Jimenez E, Hakim F, Yepes C, Useche N, Bermudez S, Asencio JL, Carranza H, Vargas C, Otero JM, Bartels C, Quintero A, Restrepo CE, Gomez S, Bernal-Vaca L, Lema M, Cardona AF, Ortiz LD, Useche N, Bermudez S, Jimenez E, Hakim F, Yepes C, Mejia JA, Bernal-Vaca L, Restrepo CE, Gomez S, Quintero A, Bartels C, Carranza H, Vargas C, Otero JM, Carlo M, Omuro A, Grommes C, Kris M, Nolan C, Pentsova E, Pietanza M, Kaley T, Carrabba G, Giammattei L, Draghi R, Conte V, Martinelli I, Caroli M, Bertani G, Locatelli M, Rampini P, Artoni A, Carrabba G, Bertani G, Cogiamanian F, Ardolino G, Zarino B, Locatelli M, Caroli M, Rampini P, Chamberlain M, Raizer J, Soffetti R, Ruda R, Brandsma D, Boogerd W, Taillibert S, Le Rhun E, Jaeckle K, van den Bent M, Wen P, Chamberlain M, Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea D, Brandes AA, Hilton M, Kerloeguen Y, Guijarro A, Cloughsey T, Choi JH, Hong YK, Conrad C, Yung WKA, deGroot J, Gilbert M, Loghin M, Penas-Prado M, Tremont I, Silberman S, Picker D, Costa R, Lycette J, Gancher S, Cullen J, Winer E, Hochberg F, Sachs G, Jeyapalan S, Dahiya S, Stevens G, Peereboom D, Ahluwalia M, Daras M, Hsu M, Kaley T, Panageas K, Curry R, Avila E, Fuente MDL, Omuro A, DeAngelis L, Desjardins A, Sampson J, Peters K, Ranjan T, Vlahovic G, Threatt S, Herndon J, Boulton S, Lally-Goss D, McSherry F, Friedman A, Friedman H, Bigner D, Gromeier M, Prust M, Kalpathy-Cramer J, Poloskova P, Jafari-Khouzani K, Gerstner E, Dietrich J, Fabi A, Villani V, Vaccaro V, Vidiri A, Giannarelli D, Piludu F, Anelli V, Carapella C, Cognetti F, Pace A, Flowers A, Flowers A, Killory B, Furuse M, Miyatake SI, Kawabata S, Kuroiwa T, Garciarena P, Anderson MD, Hamilton J, Schellingerhout D, Fuller GN, Sawaya R, Gilbert MR, Gilbert M, Pugh S, Won M, Blumenthal D, Vogelbaum M, Aldape K, Colman H, Chakravarti A, Jeraj R, Dignam J, Armstrong T, Wefel J, Brown P, Jaeckle K, Schiff D, Brachman D, Werner-Wasik M, Tremont-Lukats I, Sulman E, Mehta M, Gill B, Yun J, Goldstein H, Malone H, Pisapia D, Sonabend AM, Mckhann GK, Sisti MB, Sims P, Canoll P, Bruce JN, Girvan A, Carter G, Li L, Kaltenboeck A, Chawla A, Ivanova J, Koh M, Stevens J, Lahn M, Gore M, Hariharan S, Porta C, Bjarnason G, Bracarda S, Hawkins R, Oudard S, Zhang K, Fly K, Matczak E, Szczylik C, Grossman R, Ram Z, Hamza M, O'Brien B, Mandel J, DeGroot J, Han S, Molinaro A, Berger M, Prados M, Chang S, Clarke J, Butowski N, Hashimoto N, Chiba Y, Tsuboi A, Kinoshita M, Hirayama R, Kagawa N, Oka Y, Oji Y, Sugiyama H, Yoshimine T, Hawkins-Daarud A, Jackson PR, Swanson KR, Sarmiento JM, Ly D, Jutla J, Ortega A, Carico C, Dickinson H, Phuphanich S, Rudnick J, Patil C, Hu J, Iglseder S, Nowosielski M, Nevinny-Stickel M, Stockhammer G, Jain R, Poisson L, Scarpace L, Mikkelsen T, Kirby J, Freymann J, Hwang S, Gutman D, Jaffe C, Brat D, Flanders A, Janicki T, Burzynski S, Burzynski G, Marszalek A, Jiang C, Wang H, Jo J, Williams B, Smolkin M, Wintermark M, Shaffrey M, Schiff D, Juratli T, Soucek S, Kirsch M, Schackert G, Kakkar A, Kumar S, Bhagat U, Kumar A, Suri A, Singh M, Sharma M, Sarkar C, Suri V, Kaley T, Barani I, Chamberlain M, McDermott M, Raizer J, Rogers L, Schiff D, Vogelbaum M, Weber D, Wen P, Kalita O, Vaverka M, Hrabalek L, Zlevorova M, Trojanec R, Hajduch M, Kneblova M, Ehrmann J, Kanner AA, Wong ET, Villano JL, Ram Z, Khatua S, Fuller G, Dasgupta S, Rytting M, Vats T, Zaky W, Khatua S, Sandberg D, Foresman L, Zaky W, Kieran M, Geoerger B, Casanova M, Chisholm J, Aerts I, Bouffet E, Brandes AA, Leary SES, Sullivan M, Bailey S, Cohen K, Mason W, Kalambakas S, Deshpande P, Tai F, Hurh E, McDonald TJ, Kieran M, Hargrave D, Wen PY, Goldman S, Amakye D, Patton M, Tai F, Moreno L, Kim CY, Kim T, Han JH, Kim YJ, Kim IA, Yun CH, Jung HW, Koekkoek JAF, Reijneveld JC, Dirven L, Postma TJ, Vos MJ, Heimans JJ, Taphoorn MJB, Koeppen S, Hense J, Kong XT, Davidson T, Lai A, Cloughesy T, Nghiemphu PL, Kong DS, Choi YL, Seol HJ, Lee JI, Nam DH, Kool M, Jones DTW, Jager N, Northcott PA, Pugh T, Hovestadt V, Markant S, Esparza LA, Bourdeaut F, Remke M, Taylor MD, Cho YJ, Pomeroy SL, Schuller U, Korshunov A, Eils R, Wechsler-Reya RJ, Lichter P, Pfister SM, Krel R, Krutoshinskaya Y, Rosiello A, Seidman R, Kowalska A, Kudo T, Hata Y, Maehara T, Kumthekar P, Bridge C, Patel V, Rademaker A, Helenowski I, Mrugala M, Rockhill J, Swanson K, Grimm S, Raizer J, Meletath S, Bennett M, Nestor VA, Fink KL, Lee E, Reardon D, Schiff D, Drappatz J, Muzikansky A, Hammond S, Grimm S, Norden A, Beroukhim R, McCluskey C, Chi A, Batchelor T, Smith K, Gaffey S, Gerard M, Snodgras S, Raizer J, Wen P, Leeper H, Johnson D, Lima J, Porensky E, Cavaliere R, Lin A, Liu J, Evans J, Leuthardt E, Dacey R, Dowling J, Kim A, Zipfel G, Grubb R, Huang J, Robinson C, Simpson J, Linette G, Chicoine M, Tran D, Liubinas SV, D'Abaco GM, Moffat B, Gonzales M, Feleppa F, Nowell CJ, Gorelick A, Drummond KJ, Morokoff AP, O'Brien TJ, Kaye AH, Loghin M, Melhem-Bertrandt A, Penas-Prado M, Zaidi T, Katz R, Lupica K, Stevens G, Ly I, Hamilton S, Rostomily R, Rockhill J, Mrugala M, Mandel J, Yust-Katz S, de Groot J, Yung A, Gilbert M, Burzynski S, Janicki T, Burzynski G, Marszalek A, Pachow D, Kliese N, Kirches E, Mawrin C, McNamara MG, Lwin Z, Jiang H, Chung C, Millar BA, Sahgal A, Laperriere N, Mason WP, Megyesi J, Salehi F, Merker V, Slusarz K, Muzikansky A, Francis S, Plotkin S, Mishima K, Adachi JI, Suzuki T, Uchida E, Yanagawa T, Watanabe Y, Fukuoka K, Yanagisawa T, Wakiya K, Fujimaki T, Nishikawa R, Moiyadi A, Kannan S, Sridhar E, Gupta T, Shetty P, Jalali R, Alshami J, Lecavalier-Barsoum M, Guiot MC, Tampieri D, Kavan P, Muanza T, Nagane M, Kobayashi K, Takayama N, Shiokawa Y, Nakamura H, Makino K, Hideo T, Kuroda JI, Shinojima N, Yano S, Kuratsu JI, Nambudiri N, Arrilaga I, Dunn I, Folkerth R, Chi S, Reardon D, Nayak L, Omuro A, DeAngelis L, Robins HI, Govindan R, Gadgeel S, Kelly K, Rigas J, Reimers HJ, Peereboom D, Rosenfeld S, Garst J, Ramnath N, Wing P, Zheng M, Urban P, Abrey L, Wen P, Nayak L, DeAngelis LM, Wen PY, Brandes AA, Soffietti R, Peereboom DM, Lin NU, Chamberlain M, Macdonald D, Galanis E, Perry J, Jaeckle K, Mehta M, Stupp R, van den Bent M, Reardon DA, Norden A, Hammond S, Drappatz J, Phuphanich S, Reardon D, Wong E, Plotkin S, Lesser G, Raizer J, Batchelor T, Lee E, Kaley T, Muzikansky A, Doherty L, LaFrankie D, Ruland S, Smith K, Gerard M, McCluskey C, Wen P, Norden A, Schiff D, Ahluwalia M, Lesser G, Nayak L, Lee E, Muzikansky A, Dietrich J, Smith K, Gaffey S, McCluskey C, Ligon K, Reardon D, Wen P, Bush NAO, Kesari S, Scott B, Ohno M, Narita Y, Miyakita Y, Arita H, Matsushita Y, Yoshida A, Fukushima S, Ichimura K, Shibui S, Okamura T, Kaneko S, Omuro A, Chinot O, Taillandier L, Ghesquieres H, Soussain C, Delwail V, Lamy T, Gressin R, Choquet S, Soubeyran P, Maire JP, Benouaich-Amiel A, Lebouvier-Sadot S, Gyan E, Barrie M, del Rio MS, Gonzalez-Aguilar A, Houllier C, Tanguy ML, Hoang-Xuan K, Omuro A, Abrey L, Raizer J, Paleologos N, Forsyth P, DeAngelis L, Kaley T, Louis D, Cairncross JG, Matasar M, Mehta J, Grimm S, Moskowitz C, Sauter C, Opinaldo P, Torcuator R, Ortiz LD, Cardona AF, Hakim F, Jimenez E, Yepes C, Useche N, Bermudez S, Mejia JA, Asencio JL, Carranza H, Vargas C, Otero JM, Lema M, Pace A, Villani V, Fabi A, Carapella CM, Patel A, Allen J, Dicker D, Sheehan J, El-Deiry W, Glantz M, Tsyvkin E, Rauschkolb P, Pentsova E, Lee M, Perez A, Norton J, Uschmann H, Chamczuck A, Khan M, Fratkin J, Rahman R, Hempfling K, Norden A, Reardon DA, Nayak L, Rinne M, Doherty L, Ruland S, Rai A, Rifenburg J, LaFrankie D, Wen P, Lee E, Ranjan T, Peters K, Vlahovic G, Friedman H, Desjardins A, Reveles I, Brenner A, Ruda R, Bello L, Castellano A, Bertero L, Bosa C, Trevisan E, Riva M, Donativi M, Falini A, Soffietti R, Saran F, Chinot OL, Henriksson R, Mason W, Wick W, Nishikawa R, Dahr S, Hilton M, Garcia J, Cloughesy T, Sasaki H, Nishiyama Y, Yoshida K, Hirose Y, Schwartz M, Grimm S, Kumthekar P, Fralin S, Rice L, Drawz A, Helenowski I, Rademaker A, Raizer J, Schwartz K, Chang H, Nikolai M, Kurniali P, Olson K, Pernicone J, Sweeley C, Noel M, Sharma M, Gupta R, Suri V, Singh M, Sarkar C, Shibahara I, Sonoda Y, Saito R, Kanamori M, Yamashita Y, Kumabe T, Watanabe M, Suzuki H, Watanabe T, Ishioka C, Tominaga T, Shih K, Chowdhary S, Rosenblatt P, Weir AB, Shepard G, Williams JT, Shastry M, Hainsworth JD, Singer S, Riely GJ, Kris MG, Grommes C, Sanders MWCB, Arik Y, Seute T, Robe PAJT, Leijten FSS, Snijders TJ, Sturla L, Culhane JJ, Donahue J, Jeyapalan S, Suchorska B, Jansen N, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, Bartenstein P, Schnell O, Kreth FW, LaFougere C, Tonn JC, Taillandier L, Wittwer B, Blonski M, Faure G, De Carvalho M, Le Rhun E, Tanaka K, Sasayama T, Nishihara M, Mizukawa K, Kohmura E, Taylor S, Newell K, Graves L, Timmer M, Cramer C, Rohn G, Goldbrunner R, Turner S, Gergel T, Lacroix M, Toms S, Ueki K, Higuchi F, Sakamoto S, Kim P, Salgado MAV, Rueda AG, Urzaiz LL, Villanueva MG, Millan JMS, Cervantes ER, Pampliega RA, de Pedro MDA, Berrocal VR, Mena AC, van Zanten SV, Jansen M, van Vuurden D, Huisman M, Hoekstra O, van Dongen G, Kaspers GJ, Schlamann A, von Bueren AO, Hagel C, Kramm C, Kortmann RD, Muller K, Friedrich C, Muller K, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Gerber NU, Hau P, Kuehl J, Kortmann RD, von Bueren AO, Rutkowski S, von Bueren AO, Friedrich C, von Hoff K, Kwiecien R, Muller K, Pietsch T, Warmuth-Metz M, Kuehl J, Kortmann RD, Rutkowski S, Walker J, Tremont I, Armstrong T, Wang H, Jiang C, Wang H, Jiang C, Warren P, Robert S, Lahti A, White D, Reid M, Nabors L, Sontheimer H, Wen P, Yung A, Mellinghoff I, Lamborn K, Ramkissoon S, Cloughesy T, Rinne M, Omuro A, DeAngelis L, Gilbert M, Chi A, Batchelor T, Colman H, Chang S, Nayak L, Massacesi C, DiTomaso E, Prados M, Reardon D, Ligon K, Wong ET, Elzinga G, Chung A, Barron L, Bloom J, Swanson KD, Elzinga G, Chung A, Wong ET, Wu W, Galanis E, Wen P, Das A, Fine H, Cloughesy T, Sargent D, Yoon WS, Yang SH, Chung DS, Jeun SS, Hong YK, Yust-Katz S, Milbourne A, Diane L, Gilbert M, Armstrong T, Zaky W, Weinberg J, Fuller G, Ketonen L, McAleer MF, Ahmed N, Khatua S, Zaky W, Olar A, Stewart J, Sandberg D, Foresman L, Ketonen L, Khatua S. NEURO/MEDICAL ONCOLOGY. Neuro Oncol 2013; 15:iii98-iii135. [PMCID: PMC3823897 DOI: 10.1093/neuonc/not182] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/14/2023] Open
|
68
|
Aartsen MG, Abbasi R, Abdou Y, Ackermann M, Adams J, Aguilar JA, Ahlers M, Altmann D, Auffenberg J, Bai X, Baker M, Barwick SW, Baum V, Bay R, Beatty JJ, Bechet S, Becker Tjus J, Becker KH, Bell M, Benabderrahmane ML, Benzvi S, Berdermann J, Berghaus P, Berley D, Bernardini E, Bernhard A, Bertrand D, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohaichuk S, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Bretz HP, Brown AM, Bruijn R, Brunner J, Carson M, Casey J, Casier M, Chirkin D, Christov A, Christy B, Clark K, Clevermann F, Coenders S, Cohen S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, De Clercq C, De Ridder S, Desiati P, de With M, DeYoung T, Díaz-Vélez JC, Dunkman M, Eagan R, Eberhardt B, Eisch J, Ellsworth RW, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Franke R, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grandmont DT, Grant D, Groß A, Ha C, Haj Ismail A, Hallen P, Hallgren A, Halzen F, Hanson K, Heereman D, Heinen D, Helbing K, Hellauer R, Hickford S, Hill GC, Hoffman KD, Hoffmann R, Homeier A, Hoshina K, Huelsnitz W, Hulth PO, Hultqvist K, Hussain S, Ishihara A, Jacobi E, Jacobsen J, Jagielski K, Japaridze GS, Jero K, Jlelati O, Kaminsky B, Kappes A, Karg T, Karle A, Kelley JL, Kiryluk J, Kislat F, Kläs J, Klein SR, Köhne JH, Kohnen G, Kolanoski H, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krasberg M, Krings K, Kroll G, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Landsman H, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leute J, Lünemann J, Madsen J, Maruyama R, Mase K, Matis HS, McNally F, Meagher K, Merck M, Mészáros P, Meures T, Miarecki S, Middell E, Milke N, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Odrowski S, Olivas A, Olivo M, O'Murchadha A, Palazzo A, Paul L, Pepper JA, Pérez de los Heros C, Pfendner C, Pieloth D, Pinat E, Pirk N, Posselt J, Price PB, Przybylski GT, Rädel L, Rameez M, Rawlins K, Redl P, Reimann R, Resconi E, Rhode W, Ribordy M, Richman M, Riedel B, Rodrigues JP, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Salameh T, Sander HG, Santander M, Sarkar S, Schatto K, Scheel M, Scheriau F, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Schulz O, Seckel D, Sestayo Y, Seunarine S, Sheremata C, Smith MWE, Soldin D, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stasik A, Stezelberger T, Stokstad RG, Stößl A, Strahler EA, Ström R, Sullivan GW, Taavola H, Taboada I, Tamburro A, Tepe A, Ter-Antonyan S, Tešić G, Tilav S, Toale PA, Toscano S, Usner M, van der Drift D, van Eijndhoven N, Van Overloop A, van Santen J, Vehring M, Voge M, Vraeghe M, Walck C, Waldenmaier T, Wallraff M, Wasserman R, Weaver C, Wellons M, Wendt C, Westerhoff S, Whitehorn N, Wiebe K, Wiebusch CH, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu C, Xu DL, Xu XW, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Ziemann J, Zierke S, Zoll M. Measurement of atmospheric neutrino oscillations with IceCube. PHYSICAL REVIEW LETTERS 2013; 111:081801. [PMID: 24010427 DOI: 10.1103/physrevlett.111.081801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/16/2013] [Indexed: 06/02/2023]
Abstract
We present the first statistically significant detection of neutrino oscillations in the high-energy regime (>20 GeV) from an analysis of IceCube Neutrino Observatory data collected in 2010 and 2011. This measurement is made possible by the low-energy threshold of the DeepCore detector (~20 GeV) and benefits from the use of the IceCube detector as a veto against cosmic-ray-induced muon background. The oscillation signal was detected within a low-energy muon neutrino sample (20-100 GeV) extracted from data collected by DeepCore. A high-energy muon neutrino sample (100 GeV-10 TeV) was extracted from IceCube data to constrain systematic uncertainties. The disappearance of low-energy upward-going muon neutrinos was observed, and the nonoscillation hypothesis is rejected with more than 5σ significance. In a two-neutrino flavor formalism, our data are best described by the atmospheric neutrino oscillation parameters |Δm(32)(2)|=(2.3(-0.5)(+0.6))×10(-3) eV(2) and sin(2)(2θ(23))>0.93, and maximum mixing is favored.
Collapse
|
69
|
Aartsen MG, Abbasi R, Abdou Y, Ackermann M, Adams J, Aguilar JA, Ahlers M, Altmann D, Auffenberg J, Bai X, Baker M, Barwick SW, Baum V, Bay R, Beatty JJ, Bechet S, Becker Tjus J, Becker KH, Bell M, Benabderrahmane ML, BenZvi S, Berdermann J, Berghaus P, Berley D, Bernardini E, Bernhard A, Bertrand D, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohaichuk S, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Bretz HP, Brown AM, Bruijn R, Brunner J, Carson M, Casey J, Casier M, Chirkin D, Christov A, Christy B, Clark K, Clevermann F, Coenders S, Cohen S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, De Clercq C, De Ridder S, Desiati P, de With M, DeYoung T, Díaz-Vélez JC, Dunkman M, Eagan R, Eberhardt B, Eisch J, Ellsworth RW, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Franke R, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grant D, Groß A, Gurtner M, Ha C, Haj Ismail A, Hallen P, Hallgren A, Halzen F, Hanson K, Heereman D, Heinen D, Helbing K, Hellauer R, Hickford S, Hill GC, Hoffman KD, Hoffmann R, Homeier A, Hoshina K, Huelsnitz W, Hulth PO, Hultqvist K, Hussain S, Ishihara A, Jacobi E, Jacobsen J, Jagielski K, Japaridze GS, Jero K, Jlelati O, Kaminsky B, Kappes A, Karg T, Karle A, Kelley JL, Kiryluk J, Kislat F, Kläs J, Klein SR, Köhne JH, Kohnen G, Kolanoski H, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krasberg M, Krings K, Kroll G, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Landsman H, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leute J, Lünemann J, Madsen J, Maruyama R, Mase K, Matis HS, McNally F, Meagher K, Merck M, Mészáros P, Meures T, Miarecki S, Middell E, Milke N, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Odrowski S, Olivas A, Olivo M, O'Murchadha A, Paul L, Pepper JA, Pérez de los Heros C, Pfendner C, Pieloth D, Pinat E, Pirk N, Posselt J, Price PB, Przybylski GT, Rädel L, Rameez M, Rawlins K, Redl P, Reimann R, Resconi E, Rhode W, Ribordy M, Richman M, Riedel B, Rodrigues JP, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Salameh T, Sander HG, Santander M, Sarkar S, Schatto K, Scheel M, Scheriau F, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Schulz O, Seckel D, Sestayo Y, Seunarine S, Sheremata C, Smith MWE, Soiron M, Soldin D, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stasik A, Stezelberger T, Stokstad RG, Stößl A, Strahler EA, Ström R, Sullivan GW, Taavola H, Taboada I, Tamburro A, Ter-Antonyan S, Tešić G, Tilav S, Toale PA, Toscano S, Usner M, van der Drift D, van Eijndhoven N, Van Overloop A, van Santen J, Vehring M, Voge M, Vraeghe M, Walck C, Waldenmaier T, Wallraff M, Wasserman R, Weaver C, Wellons M, Wendt C, Westerhoff S, Whitehorn N, Wiebe K, Wiebusch CH, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu C, Xu DL, Xu XW, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Ziemann J, Zierke S, Zilles A, Zoll M. First observation of PeV-energy neutrinos with IceCube. PHYSICAL REVIEW LETTERS 2013; 111:021103. [PMID: 23889381 DOI: 10.1103/physrevlett.111.021103] [Citation(s) in RCA: 81] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2013] [Indexed: 06/02/2023]
Abstract
We report on the observation of two neutrino-induced events which have an estimated deposited energy in the IceCube detector of 1.04±0.16 and 1.14±0.17 PeV, respectively, the highest neutrino energies observed so far. These events are consistent with fully contained particle showers induced by neutral-current ν(e,μ,τ) (ν(e,μ,τ)) or charged-current ν(e) (ν(e)) interactions within the IceCube detector. The events were discovered in a search for ultrahigh energy neutrinos using data corresponding to 615.9 days effective live time. The expected number of atmospheric background is 0.082±0.004(stat)(-0.057)(+0.041)(syst). The probability of observing two or more candidate events under the atmospheric background-only hypothesis is 2.9×10(-3) (2.8σ) taking into account the uncertainty on the expected number of background events. These two events could be a first indication of an astrophysical neutrino flux; the moderate significance, however, does not permit a definitive conclusion at this time.
Collapse
|
70
|
Casey R, Bell M, Keane M, Smyth A. An unusual presentation of MEN2A. BMJ Case Rep 2013; 2013:bcr-2012-007171. [PMID: 23749818 DOI: 10.1136/bcr-2012-007171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
A 35-year-old woman presented with non-specific symptoms of fatigue and weight loss. Radiological investigations diagnosed a metastatic process and large bilateral adrenal masses. Histology from a liver biopsy and skin biopsy confirmed a diagnosis of metastatic medullary thyroid cancer. Further biochemical investigations revealed a positive 24-h urinary metanephrine collection and evidence of primary hyperparathyroidism. Genetic testing confirmed a mutant RET oncogene, confirming our clinical suspicion of multiple endocrine neoplasia type 2 (MEN2A) syndrome. The patient had no family history of endocrine disease and presented with widespread metastatic disease, making this an unusual presentation of MEN2A syndrome. Furthermore cutaneous metastases are rarely encountered in conjunction with metastatic medullary thyroid cancer. This case draws attention to the importance of genetic counselling in first-degree relatives of patients with confirmed MEN2A. This allows for timely diagnosis and reduced morbidity and mortality.
Collapse
|
71
|
Scott J, Gavin J, Egan AM, Avalos G, Dennedy MC, Bell M, Dunne F. The prevalence of diabetes, pre-diabetes and the metabolic syndrome in an Irish regional homeless population. QJM 2013; 106:547-53. [PMID: 23536367 DOI: 10.1093/qjmed/hct063] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Diabetes is a major chronic health condition. Prevalence is rising, superseding public health estimates. Chronic diseases are more common among lower socioeconomic groups, for example, the homeless population. There is paucity of data on the health status of the homeless population in Ireland, and the prevalence of diabetes and associated cardiovascular risk factors is unknown. AIM We aimed to assess the prevalence of diabetes, pre-diabetes and the metabolic syndrome (MetS) in an Irish regional homeless population. DESIGN This study is a cross-sectional study of the homeless population living in a regional university city of Ireland. METHODS After informed consent and following an overnight fast, blood was drawn for fasting plasma glucose, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein and glycosylated haemoglobin (HbA1c). A 75 g glucose load was given orally and an oral glucose tolerance test completed. Anthropometric measurements and blood pressure were recorded. Smoking, alcohol and drug status were noted. RESULTS Of the 252 participants, 8% (n = 20), 10% (n = 24) and 21% (n = 54) were diagnosed with type 2 diabetes, pre-diabetes and MetS, respectively. Obesity (body mass index >30) was present in 22%, while 90% displayed abdominal obesity. Participants who screened positive for diabetes, pre-diabetes and MetS demonstrated an inferior cardiovascular risk profile. CONCLUSION The prevalence of diabetes, pre-diabetes and MetS in this homeless population is in keeping with national estimates. As this cohort is less likely to seek health care, this may result in later diagnosis and a greater risk of diabetic complications at presentation.
Collapse
|
72
|
Aartsen MG, Abbasi R, Abdou Y, Ackermann M, Adams J, Aguilar JA, Ahlers M, Altmann D, Auffenberg J, Bai X, Baker M, Barwick SW, Baum V, Bay R, Beattie K, Beatty JJ, Bechet S, Becker Tjus J, Becker KH, Bell M, Benabderrahmane ML, BenZvi S, Berdermann J, Berghaus P, Berley D, Bernardini E, Bernhard A, Bertrand D, Besson DZ, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohaichuk S, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Brown AM, Bruijn R, Brunner J, Buitink S, Carson M, Casey J, Casier M, Chirkin D, Christy B, Clark K, Clevermann F, Cohen S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, De Clercq C, De Ridder S, Desiati P, de Vries-Uiterweerd G, de With M, DeYoung T, Díaz-Vélez JC, Dreyer J, Dunkman M, Eagan R, Eberhardt B, Eisch J, Ellsworth RW, Engdegård O, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Franke R, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Goodman JA, Góra D, Grant D, Groß A, Gurtner M, Ha C, Haj Ismail A, Hallgren A, Halzen F, Hanson K, Heereman D, Heimann P, Heinen D, Helbing K, Hellauer R, Hickford S, Hill GC, Hoffman KD, Hoffmann R, Homeier A, Hoshina K, Huelsnitz W, Hulth PO, Hultqvist K, Hussain S, Ishihara A, Jacobi E, Jacobsen J, Japaridze GS, Jero K, Jlelati O, Kaminsky B, Kappes A, Karg T, Karle A, Kelley JL, Kiryluk J, Kislat F, Kläs J, Klein SR, Köhne JH, Kohnen G, Kolanoski H, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krasberg M, Kroll G, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Landsman H, Larson MJ, Lesiak-Bzdak M, Leute J, Lünemann J, Madsen J, Maruyama R, Mase K, Matis HS, McNally F, Meagher K, Merck M, Mészáros P, Meures T, Miarecki S, Middell E, Milke N, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Odrowski S, Olivas A, Olivo M, O'Murchadha A, Panknin S, Paul L, Pepper JA, Pérez de los Heros C, Pfendner C, Pieloth D, Pirk N, Posselt J, Price PB, Przybylski GT, Rädel L, Rawlins K, Redl P, Resconi E, Rhode W, Ribordy M, Richman M, Riedel B, Rodrigues JP, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Salameh T, Sander HG, Santander M, Sarkar S, Schatto K, Scheel M, Scheriau F, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönherr L, Schönwald A, Schukraft A, Schulte L, Schulz O, Seckel D, Seo SH, Sestayo Y, Seunarine S, Sheremata C, Smith MWE, Soiron M, Soldin D, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stasik A, Stezelberger T, Stokstad RG, Stößl A, Strahler EA, Ström R, Sullivan GW, Taavola H, Taboada I, Tamburro A, Ter-Antonyan S, Tilav S, Toale PA, Toscano S, Usner M, van der Drift D, van Eijndhoven N, Van Overloop A, van Santen J, Vehring M, Voge M, Vraeghe M, Walck C, Waldenmaier T, Wallraff M, Wasserman R, Weaver C, Wellons M, Wendt C, Westerhoff S, Whitehorn N, Wiebe K, Wiebusch CH, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu C, Xu DL, Xu XW, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Ziemann J, Zierke S, Zilles A, Zoll M. Measurement of the atmospheric νe flux in IceCube. PHYSICAL REVIEW LETTERS 2013; 110:151105. [PMID: 25167245 DOI: 10.1103/physrevlett.110.151105] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/19/2012] [Revised: 03/14/2013] [Indexed: 06/03/2023]
Abstract
We report the first measurement of the atmospheric electron neutrino flux in the energy range between approximately 80 GeV and 6 TeV, using data recorded during the first year of operation of IceCube's DeepCore low-energy extension. Techniques to identify neutrinos interacting within the DeepCore volume and veto muons originating outside the detector are demonstrated. A sample of 1029 events is observed in 281 days of data, of which 496±66(stat)±88(syst) are estimated to be cascade events, including both electron neutrino and neutral current events. The rest of the sample includes residual backgrounds due to atmospheric muons and charged current interactions of atmospheric muon neutrinos. The flux of the atmospheric electron neutrinos is consistent with models of atmospheric neutrinos in this energy range. This constitutes the first observation of electron neutrinos and neutral current interactions in a very large volume neutrino telescope optimized for the TeV energy range.
Collapse
|
73
|
Aartsen MG, Abbasi R, Abdou Y, Ackermann M, Adams J, Aguilar JA, Ahlers M, Altmann D, Auffenberg J, Bai X, Baker M, Barwick SW, Baum V, Bay R, Beattie K, Beatty JJ, Bechet S, Becker Tjus J, Becker KH, Bell M, Benabderrahmane ML, BenZvi S, Berdermann J, Berghaus P, Berley D, Bernardini E, Bernhard A, Bertrand D, Besson DZ, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohaichuk S, Bohm C, Bose D, Böser S, Botner O, Brayeur L, Brown AM, Bruijn R, Brunner J, Buitink S, Carson M, Casey J, Casier M, Chirkin D, Christy B, Clark K, Clevermann F, Cohen S, Cowen DF, Cruz Silva AH, Danninger M, Daughhetee J, Davis JC, De Clercq C, De Ridder S, Desiati P, de Vries-Uiterweerd G, de With M, DeYoung T, Díaz-Vélez JC, Dreyer J, Dunkman M, Eagan R, Eberhardt B, Eisch J, Ellsworth RW, Engdegård O, Euler S, Evenson PA, Fadiran O, Fazely AR, Fedynitch A, Feintzeig J, Feusels T, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Franckowiak A, Franke R, Frantzen K, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Goodman JA, Góra D, Grant D, Groß A, Gurtner M, Ha C, Haj Ismail A, Hallgren A, Halzen F, Hanson K, Heereman D, Heimann P, Heinen D, Helbing K, Hellauer R, Hickford S, Hill GC, Hoffman KD, Hoffmann R, Homeier A, Hoshina K, Huelsnitz W, Hulth PO, Hultqvist K, Hussain S, Ishihara A, Jacobi E, Jacobsen J, Japaridze GS, Jero K, Jlelati O, Kaminsky B, Kappes A, Karg T, Karle A, Kelley JL, Kiryluk J, Kislat F, Kläs J, Klein SR, Köhne JH, Kohnen G, Kolanoski H, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krasberg M, Kroll G, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Landsman H, Larson MJ, Lesiak-Bzdak M, Leute J, Lünemann J, Madsen J, Maruyama R, Mase K, Matis HS, McNally F, Meagher K, Merck M, Mészáros P, Meures T, Miarecki S, Middell E, Milke N, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Odrowski S, Olivas A, Olivo M, O'Murchadha A, Paul L, Pepper JA, Pérez de los Heros C, Pfendner C, Pieloth D, Pirk N, Posselt J, Price PB, Przybylski GT, Rädel L, Rawlins K, Redl P, Resconi E, Rhode W, Ribordy M, Richman M, Riedel B, Rodrigues JP, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Salameh T, Sander HG, Santander M, Sarkar S, Schatto K, Scheel M, Scheriau F, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönherr L, Schönwald A, Schukraft A, Schulte L, Schulz O, Seckel D, Seo SH, Sestayo Y, Seunarine S, Sheremata C, Smith MWE, Soiron M, Soldin D, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stasik A, Stezelberger T, Stokstad RG, Stößl A, Strahler EA, Ström R, Sullivan GW, Taavola H, Taboada I, Tamburro A, Ter-Antonyan S, Tilav S, Toale PA, Toscano S, Usner M, van der Drift D, van Eijndhoven N, Van Overloop A, van Santen J, Vehring M, Voge M, Vraeghe M, Walck C, Waldenmaier T, Wallraff M, Wasserman R, Weaver C, Wellons M, Wendt C, Westerhoff S, Whitehorn N, Wiebe K, Wiebusch CH, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu C, Xu DL, Xu XW, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Ziemann J, Zierke S, Zilles A, Zoll M. Search for dark matter annihilations in the sun with the 79-string IceCube detector. PHYSICAL REVIEW LETTERS 2013; 110:131302. [PMID: 23581307 DOI: 10.1103/physrevlett.110.131302] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/17/2012] [Revised: 02/20/2013] [Indexed: 06/02/2023]
Abstract
We have performed a search for muon neutrinos from dark matter annihilation in the center of the Sun with the 79-string configuration of the IceCube neutrino telescope. For the first time, the DeepCore subarray is included in the analysis, lowering the energy threshold and extending the search to the austral summer. The 317 days of data collected between June 2010 and May 2011 are consistent with the expected background from atmospheric muons and neutrinos. Upper limits are set on the dark matter annihilation rate, with conversions to limits on spin-dependent and spin-independent scattering cross sections of weakly interacting massive particles (WIMPs) on protons, for WIMP masses in the range 20-5000 GeV/c2. These are the most stringent spin-dependent WIMP-proton cross section limits to date above 35 GeV/c2 for most WIMP models.
Collapse
|
74
|
DiNicola AF, McClain AM, Scott N, Bahadori AH, Bell M. RE: body mass indices in deployed military personnel and tobacco product usage. Mil Med 2013; 178:iv. [PMID: 23356106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023] Open
|
75
|
Mårtensson J, Martling CR, Bell M. Novel biomarkers of acute kidney injury and failure: clinical applicability. Br J Anaesth 2012; 109:843-50. [DOI: 10.1093/bja/aes357] [Citation(s) in RCA: 191] [Impact Index Per Article: 15.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
|